公司资料
ADC Therapeutics 股价、新闻与催化剂
- 股票代码:
- ADCT
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- Switzerland
股票表现
1.10 USD (+8.91%)
收盘价
最后更新: 2026年8月17日
403M USD
市值
股价为何变动
As of Aug 17, 2026, ADCT closed up 8.91% at $1.10. No new same-company headline was identified in the current news window.
公司概览
业务概览
ADC Therapeutics is an oncology company focused on antibody-drug conjugates for cancer. Its platform is built around delivering cytotoxic payloads directly into tumor cells.
所在地与行业分类
Headquartered in Switzerland and listed on NASDAQ as an ADR, ADC Therapeutics has a global oncology-biotech profile.
商业模式特征
The company depends on clinical data, commercial execution, and the ability to sustain a differentiated ADC franchise.
生物医药行业定位
ADC Therapeutics is a classic oncology catalyst name whose stock reacts to readouts and product execution.
未来催化剂
- ADC Therapeutics’ catalysts are ZYNLONTA execution, employee-inducement grants / pipeline updates, and any commercial progress that proves the franchise can keep stabilizing. The market will focus on whether the company can turn a niche ADC into a more durable asset.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。